Literature DB >> 17577799

Successful use of intraventricular and intravenous rituximab therapy for refractory primary CNS lymphoma in a child.

Canan Akyuz, G Burca Aydin, Aysenur Cila, Nejat Akalan, Figen Soylemezoglu, Mustafa Cengiz, Nalan Yazici, Munevver Buyukpamukcu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17577799     DOI： 10.1080/10428190601142831

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

Review 1.  Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation.

Authors:  Frank Lieberman; Victor Yazbeck; Anastasios Raptis; Raymond Felgar; Michael Boyiadzis
Journal:  J Neurooncol       Date:  2011-10-26       Impact factor: 4.130

Review 2.  Management of elderly patients with primary central nervous system lymphoma.

Authors:  Mariza Daras; Lisa M DeAngelis
Journal:  Curr Neurol Neurosci Rep       Date:  2013-05       Impact factor: 5.081

3.  A successful treatment of relapsed primary CNS lymphoma patient with intraventricular rituximab followed by high-dose chemotherapy with autologous stem cell rescue.

Authors:  Sung Jin Hong; Jin Seok Kim; Jong Hee Chang; Kyoung Min Kim; Soo Jeong Kim; Hye Won Lee; June-Won Cheong; Seung Tae Lee; Yoo Hong Min
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.